Precision Pharma Ltd. is a specialty pharmaceutical company focused on oncology and critical care therapeutics. The company has 15 approved products and a pipeline of 8 molecules under various stages of clinical trials.
Price Band
₹720 – ₹756
Lot Size
19 shares
Issue Size
₹907.2 Cr
Listing Price
₹890
Sector
Pharmaceuticals
Founded
2010
Headquarters
Hyderabad, Telangana
Review Summary
Exceptional fundamentals with a strong product pipeline. High P/E but the oncology focus commands premium valuations. Strongly recommended.
Sale Type
Book Built
Issue Type
Fresh Issue + OFS
Face Value
₹2
Pre-Issue Holding
76%
Post-Issue Holding
58.4%
Listing At
BSE, NSE
Issue Breakdown
Fresh Issue
₹604.8 Cr
80,00,000 shares
Offer for Sale
₹302.4 Cr
40,00,000 shares
Open Date
20 Jan 2026
Close Date
22 Jan 2026
Allotment Date
24 Jan 2026
Refund Date
25 Jan 2026
Credit Date
25 Jan 2026
Listing Date
27 Jan 2026
| Year | Assets | Revenue | PAT | Net Worth |
|---|---|---|---|---|
| FY2025 | 1,85,000 | 1,42,000 | 28,500 | 78,000 |
| FY2024 | 1,55,000 | 1,12,000 | 21,200 | 55,000 |
Est: ₹876
Est: ₹891
Est: ₹896
Est: ₹886
20 Jan 2026
21 Jan 2026
22 Jan 2026
29,50,000 applications
P/E Ratio
31.8x
ROE
36.5%
EPS
₹23.75
P/BV
9.7x
Market Cap
₹9072.0 Cr
Registrar
Link Intime India Pvt Ltd
Lead Managers
Morgan Stanley India, Goldman Sachs India